Table 2 Clinico-pathological and radiological characteristics of patients with TTF-1 positive primary breast cancers
Patient number | Sample type | TTF-1 expression (staining index) | Tumor diameter (mm) | Grade | Tumor-positive lymph-nodes | ER | PR | Her2 | CK 5/6 and/or P-cadherin | Ki 67 (%) | Mode of presentation | Mammo-graphy findings | Distance from skin (mm) | Follow-up time after tumor diagnosis (months) | Status |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | SS | Weak (2) | 27 | 3 | 1/12 | - | - | + | + | 50,5 | Screening | Stellate opacity | 47 | 29 | DEAD |
2 | SS | Strong (9) | 15 | 1 | 0/3 | + | + | - | - | 25,4 | Interval | Irregular microlobulated density | 36 | 61 | AW |
3 | SS | Weak (3) | 22 | 3 | 1/21 | - | - | - | + | 41,2 | Interval | Diffuse density | 30 | 38 | AW |
4 | SS | Weak (2) | 9 | 2 | 1/11 | + | + | - | - | 14,5 | Screening | Irregular partially rounded mass | 8 | 60 | AW |
5 | SS | Weak (2) | 21 | 3 | 1/14 | - | - | - | + | 41,2 | Screening | Irregular density | 18 | 49 | AW |
6 | SS | Strong (9) | 17 | 2 | 1/8 | + | + | - | - | 22,9 | Screening | Irregular density | 33 | 54 | AW |
7 | CNB | Strong (6) | 70 | 3 | 0/1 | + | - | - | + | 55,4 | Interval | Lobulated mass density | 16 | 60 | AW |